Gout is caused by chronic hyperuricaemia and is managed acutely with NSAIDs or colchicine. Urate-lowering therapy (ULT) is recommended for patients with >= 2 attacks in 12 months, tophi, renal disease, uric acid renal stones, or prophylaxis if on cytotoxics or diuretics. Allopurinol is first-line ULT, with an initial dose of 100 mg od and titrated to aim for a serum uric acid of < 300 µmol/l. Lifestyle modifications include reducing alcohol intake, losing weight if obese, and avoiding high-purine foods. Consideration should be given to stopping precipitating drugs and losartan may be suitable for patients with coexistent hypertension.

Functions of the Proximal Convoluted Tubule in the Nephron

The proximal convoluted tubule (PCT) is a crucial part of the nephron, responsible for several important functions. One of its primary roles is the reabsorption of sodium, which occurs through active transport facilitated by the numerous mitochondria in the epithelial cells. This creates a concentration gradient that allows for the passive reabsorption of water. Glucose is also reabsorbed in the PCT through secondary active transport, driven by the sodium gradient. The PCT also regulates the pH of the filtrate by exchanging hydrogen ions for bicarbonate ions. Additionally, the PCT is the primary site for ammoniagenesis, which involves the breakdown of glutamine to α-ketoglutarate. Finally, the regulation of urine concentration occurs in the distal convoluted tubule and collecting duct under the influence of vasopressin.

Depression is a prevalent psychiatric issue in patients with Parkinson’s disease, with approximately 40% of individuals experiencing it, despite dementia being a common comorbidity.

Parkinson’s disease is a progressive neurodegenerative condition that occurs when dopaminergic neurons in the substantia nigra degenerate. This leads to a classic triad of symptoms, including bradykinesia, tremor, and rigidity, which are typically asymmetrical. The disease is more common in men and is usually diagnosed around the age of 65. Bradykinesia is characterized by a poverty of movement, shuffling steps, and difficulty initiating movement. Tremors are most noticeable at rest and typically occur in the thumb and index finger. Rigidity can be either lead pipe or cogwheel, and other characteristic features include mask-like facies, flexed posture, and micrographia. Psychiatric features such as depression, dementia, and sleep disturbances may also occur. Diagnosis is usually clinical, but if there is difficulty differentiating between essential tremor and Parkinson’s disease, 123I‑FP‑CIT single photon emission computed tomography (SPECT) may be considered.

The Importance of ACE Inhibitors in Post-MI Patients with Vascular Disease and Diabetes

Following a myocardial infarction (MI), the National Institute for Health and Care Excellence (NICE) recommends the use of angiotensin-converting enzyme (ACE) inhibitors for all patients, regardless of left ventricular function. This is based on evidence from trials such as PROGRESS and HOPE, which demonstrate the benefits of ACE inhibitors in patients with vascular disease. Additionally, for patients with diabetes, the use of ACE inhibitors is preferable. The benefits of ACE inhibition are not solely related to blood pressure reduction, but also include favorable local vascular and myocardial effects. Calcium channel blockers, such as amlodipine and diltiazem, are not recommended for post-MI patients with systolic dysfunction. Nicorandil should also be avoided. Clopidogrel is the preferred antiplatelet for patients with clinical vascular disease who have had an MI and a stroke. Blood pressure should be optimized in post-MI patients, and further antihypertensive therapy may be necessary, including the addition of an ACE inhibitor to achieve the desired level.

A newborn has micrognathia, low-set ears, rocker bottom feet, and overlapping fingers, which are indicative of Edwards Syndrome. This condition, also known as Trisomy 18, is the second most common trisomy after Down Syndrome. Unfortunately, the outcome for infants with Edwards Syndrome is poor, with many dying in-utero and few surviving beyond one week. There are several ultrasound markers that suggest Edwards Syndrome, including cardiac malformations, choroid plexus cysts, neural tube defects, abnormal hand and feet position, exomphalos, growth restriction, single umbilical artery, polyhydramnios, and small placenta. While these markers are not specific to Edwards Syndrome, they increase the likelihood of diagnosis when present together. To confirm the diagnosis, karyotype analysis of placental or amniotic fluid should be performed with patient consent. Infections such as rubella, cytomegalovirus, and varicella zoster should also be considered in the differential diagnosis of multiple fetal abnormalities, and maternal viral serology may be helpful in diagnosis.

Childhood syndromes are a group of medical conditions that affect children and are characterized by a set of common features. Patau syndrome, also known as trisomy 13, is a syndrome that is characterized by microcephaly, small eyes, cleft lip/palate, polydactyly, and scalp lesions. Edward’s syndrome, also known as trisomy 18, is characterized by micrognathia, low-set ears, rocker bottom feet, and overlapping of fingers. Fragile X syndrome is characterized by learning difficulties, macrocephaly, long face, large ears, and macro-orchidism. Noonan syndrome is characterized by a webbed neck, pectus excavatum, short stature, and pulmonary stenosis. Pierre-Robin syndrome is characterized by micrognathia, posterior displacement of the tongue, and cleft palate. Prader-Willi syndrome is characterized by hypotonia, hypogonadism, and obesity. William’s syndrome is characterized by short stature, learning difficulties, friendly, extrovert personality, and transient neonatal hypercalcaemia. Cri du chat syndrome, also known as chromosome 5p deletion syndrome, is characterized by a characteristic cry, feeding difficulties and poor weight gain, learning difficulties, microcephaly and micrognathism, and hypertelorism. It is important to note that Treacher-Collins syndrome is similar to Pierre-Robin syndrome, but it is autosomal dominant and usually has a family history of similar problems.

According to NICE guidelines, women experiencing vasomotor symptoms during menopause can be prescribed fluoxetine, a selective serotonin uptake inhibitor (SSRI). While clonidine is also approved for treating these symptoms, its effectiveness is not well-established and it can cause side effects such as dry mouth, sedation, depression, and fluid retention. Gabapentin is being studied for its potential to reduce hot flushes, but more research is needed.

Managing Menopause: Lifestyle Modifications, Hormone Replacement Therapy, and Non-Hormone Replacement Therapy

Menopause is a natural biological process that marks the end of a woman’s reproductive years. It is diagnosed when a woman has not had a period for 12 consecutive months. Menopausal symptoms are common and can last for up to 7 years, with varying degrees of severity and duration. The management of menopause can be divided into three categories: lifestyle modifications, hormone replacement therapy (HRT), and non-hormone replacement therapy.

Lifestyle modifications can help manage menopausal symptoms such as hot flushes, sleep disturbance, mood changes, and cognitive symptoms. Regular exercise, weight loss, stress reduction, and good sleep hygiene are recommended. For women who cannot or do not want to take HRT, non-hormonal treatments such as fluoxetine, citalopram, or venlafaxine for vasomotor symptoms, vaginal lubricants or moisturizers for vaginal dryness, and cognitive behavior therapy or antidepressants for psychological symptoms can be prescribed.

HRT is a treatment option for women with moderate to severe menopausal symptoms. However, it is contraindicated in women with current or past breast cancer, any estrogen-sensitive cancer, undiagnosed vaginal bleeding, or untreated endometrial hyperplasia. HRT brings certain risks, including venous thromboembolism, stroke, coronary heart disease, breast cancer, and ovarian cancer. Women should be advised of these risks and the fact that symptoms typically last for 2-5 years.

When stopping HRT, it is important to gradually reduce the dosage to limit recurrence of symptoms in the short term. However, in the long term, there is no difference in symptom control. Women who experience ineffective treatment, ongoing side effects, or unexplained bleeding should be referred to secondary care. Overall, managing menopause requires a personalized approach that takes into account a woman’s medical history, preferences, and individual symptoms.

Medications to Avoid in Patients with Heart Failure

Heart failure is a serious condition that requires careful management of medications. Some medications can exacerbate heart failure and should be avoided. Thiazolidinediones, such as pioglitazone, are contraindicated as they cause fluid retention. Verapamil has a negative inotropic effect and should be used with caution. NSAIDs and glucocorticoids can also cause fluid retention and should be used with caution. However, low-dose aspirin is an exception as many patients with heart failure also have coexistent cardiovascular disease and the benefits of taking aspirin easily outweigh the risks. Class I antiarrhythmics, such as flecainide, have a negative inotropic and proarrhythmic effect and should be avoided. It is important for healthcare providers to be aware of these medications and to carefully consider their use in patients with heart failure.

Phenytoin treatment may lead to the development of Dupuytren’s contracture as a potential adverse effect.

Understanding Dupuytren’s Contracture

Dupuytren’s contracture is a condition that affects about 5% of the population. It is more common in older men and those with a family history of the condition. The causes of Dupuytren’s contracture include manual labor, phenytoin treatment, alcoholic liver disease, diabetes mellitus, and trauma to the hand.

The condition typically affects the ring finger and little finger, causing them to become bent and difficult to straighten. In severe cases, the hand may not be able to be placed flat on a table.

Surgical treatment may be necessary when the metacarpophalangeal joints cannot be straightened.

Differential diagnosis of recurrent positional vertigo

Recurrent positional vertigo is a common complaint that can have various underlying causes. One of the most frequent diagnoses is benign positional paroxysmal vertigo (BPPV), which typically affects middle-aged and older women and is triggered by specific head movements. BPPV is diagnosed based on the patient’s history and confirmed with the Hallpike manoeuvre, which elicits characteristic nystagmus. Treatment options include canalith repositioning manoeuvres and vestibular rehabilitation exercises.

However, other conditions may mimic BPPV or coexist with it, and therefore a thorough differential diagnosis is necessary. Migraine-associated vertigo is a type of vestibular migraine that can cause brief episodes of vertigo without headache, but usually has a longer duration and is not triggered by positional changes. Posterior circulation ischaemia, which affects the brainstem and cerebellum, can also cause vertigo, but typically presents with other neurological symptoms and has a more acute onset. Postural hypotension, which results from a drop in blood pressure upon standing, can cause dizziness and syncope, but is not usually related to head movements. Labyrinthitis, an inflammation of the inner ear, can cause vertigo and hearing loss, but is not typically triggered by positional changes.

Therefore, a careful history and physical examination, including a neurological assessment, are essential to differentiate between these conditions and guide appropriate management. In some cases, further testing such as imaging or vestibular function tests may be necessary to confirm the diagnosis.

Myocardial infarction (MI) is a serious condition that requires proper management to prevent further complications. In 2013, NICE released guidelines on the secondary prevention of MI. One of the key recommendations is the use of four drugs: dual antiplatelet therapy (aspirin plus a second antiplatelet agent), ACE inhibitor, beta-blocker, and statin. Patients are also advised to adopt a Mediterranean-style diet and engage in regular exercise. Sexual activity may resume four weeks after an uncomplicated MI, and PDE5 inhibitors may be used six months after the event.

Most patients with acute coronary syndrome are now given dual antiplatelet therapy, with ticagrelor and prasugrel being the preferred options. The treatment period for these drugs is 12 months, after which they should be stopped. However, this period may be adjusted for patients at high risk of bleeding or further ischaemic events. Additionally, patients with heart failure and left ventricular systolic dysfunction should be treated with an aldosterone antagonist within 3-14 days of the MI, preferably after ACE inhibitor therapy.

Overall, the NICE guidelines provide a comprehensive approach to the secondary prevention of MI. By following these recommendations, patients can reduce their risk of further complications and improve their overall health outcomes.

The neonate is diagnosed with congenital rubella syndrome, which is characterized by sensorineural deafness, eye abnormalities, and congenital heart disease. The risk of fetal infection is highest if the mother contracts the virus during the first trimester of pregnancy. Antenatal cytomegalovirus infection can lead to cerebral calcification, microcephaly, and sensorineural deafness. HIV does not pose a physical risk to the developing fetus, but there is a risk of perinatal transmission. Parvovirus B19 can cause hydrops fetalis and fetal death. Toxoplasmosis can result in intracranial calcification, hydrocephalus, and epilepsy in the affected child.

Rubella and Pregnancy: Risks, Features, Diagnosis, and Management

Rubella, also known as German measles, is a viral infection caused by the togavirus. Thanks to the introduction of the MMR vaccine, it is now rare. However, if contracted during pregnancy, there is a risk of congenital rubella syndrome, which can cause serious harm to the fetus. It is important to note that the incubation period is 14-21 days, and individuals are infectious from 7 days before symptoms appear to 4 days after the onset of the rash.

The risk of damage to the fetus is highest in the first 8-10 weeks of pregnancy, with a risk as high as 90%. However, damage is rare after 16 weeks. Features of congenital rubella syndrome include sensorineural deafness, congenital cataracts, congenital heart disease (e.g. patent ductus arteriosus), growth retardation, hepatosplenomegaly, purpuric skin lesions, ‘salt and pepper’ chorioretinitis, microphthalmia, and cerebral palsy.

If a suspected case of rubella in pregnancy arises, it should be discussed immediately with the local Health Protection Unit (HPU) as type/timing of investigations may vary. IgM antibodies are raised in women recently exposed to the virus. It should be noted that it is very difficult to distinguish rubella from parvovirus B19 clinically. Therefore, it is important to also check parvovirus B19 serology as there is a 30% risk of transplacental infection, with a 5-10% risk of fetal loss.

If a woman is tested at any point and no immunity is demonstrated, they should be advised to keep away from people who might have rubella. Non-immune mothers should be offered the MMR vaccination in the post-natal period. However, MMR vaccines should not be administered to women known to be pregnant or attempting to become pregnant.

Common Gastrointestinal Disorders in Toddlers

Intussusception is a common gastrointestinal disorder in toddlers, typically affecting those aged 9-12 months. Symptoms include slimy or jelly-like red stools, abdominal pain, and a palpable mass or fullness. Diagnosis is made through ultrasound imaging and treatment usually involves an enema, although surgery may be necessary in complicated cases.

Pyloric stenosis is another disorder that can occur in the first few weeks of a baby’s life. It causes forceful projectile vomiting immediately after feeds and is diagnosed through ultrasound imaging. Treatment involves surgery with a pyloromyotomy.

Campylobacter-related gastroenteritis is rare in toddlers, especially considering that they typically only consume baby food.

Colorectal cancer is almost unheard of in this age group.

Hirschsprung’s disease is a congenital disorder that causes bowel obstruction, resulting in vomiting and failure to pass stools. It is typically diagnosed through a rectal biopsy and treated with surgical removal of the affected part of the bowel.

Injectable Contraceptives: Depo Provera

Injectable contraceptives are a popular form of birth control in the UK, with Depo Provera being the main option available. This contraceptive contains 150mg of medroxyprogesterone acetate and is administered via intramuscular injection every 12 weeks. It can be given up to 14 weeks after the last dose without the need for extra precautions. The primary method of action is by inhibiting ovulation, while secondary effects include cervical mucus thickening and endometrial thinning.

However, there are some disadvantages to using Depo Provera. Once the injection is given, it cannot be reversed, and there may be a delayed return to fertility of up to 12 months. Adverse effects may include irregular bleeding and weight gain, and there is a potential increased risk of osteoporosis. It should only be used in adolescents if no other method of contraception is suitable.

It is important to note that there are contraindications to using Depo Provera, such as current breast cancer (UKMEC 4) or past breast cancer (UKMEC 3). While Noristerat is another injectable contraceptive licensed in the UK, it is rarely used in clinical practice and is given every 8 weeks. Overall, injectable contraceptives can be an effective form of birth control, but it is important to weigh the potential risks and benefits before deciding on this method.

Fluoxetine is the preferred SSRI for children and adolescents.

Selective serotonin reuptake inhibitors (SSRIs) are commonly used as the first-line treatment for depression. Citalopram and fluoxetine are the preferred SSRIs, while sertraline is recommended for patients who have had a myocardial infarction. However, caution should be exercised when prescribing SSRIs to children and adolescents. Gastrointestinal symptoms are the most common side-effect, and patients taking SSRIs are at an increased risk of gastrointestinal bleeding. Patients should also be aware of the possibility of increased anxiety and agitation after starting a SSRI. Fluoxetine and paroxetine have a higher propensity for drug interactions.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning regarding the use of citalopram due to its association with dose-dependent QT interval prolongation. As a result, citalopram and escitalopram should not be used in patients with congenital long QT syndrome, known pre-existing QT interval prolongation, or in combination with other medicines that prolong the QT interval. The maximum daily dose of citalopram is now 40 mg for adults, 20 mg for patients older than 65 years, and 20 mg for those with hepatic impairment.

When initiating antidepressant therapy, patients should be reviewed by a doctor after 2 weeks. Patients under the age of 25 years or at an increased risk of suicide should be reviewed after 1 week. If a patient responds well to antidepressant therapy, they should continue treatment for at least 6 months after remission to reduce the risk of relapse. When stopping a SSRI, the dose should be gradually reduced over a 4 week period, except for fluoxetine. Paroxetine has a higher incidence of discontinuation symptoms, including mood changes, restlessness, difficulty sleeping, unsteadiness, sweating, gastrointestinal symptoms, and paraesthesia.

When considering the use of SSRIs during pregnancy, the benefits and risks should be weighed. Use during the first trimester may increase the risk of congenital heart defects, while use during the third trimester can result in persistent pulmonary hypertension of the newborn. Paroxetine has an increased risk of congenital malformations, particularly in the first trimester.

Skin cancer can take on different forms, including basal cell carcinoma (BCC), actinic keratosis, herpes zoster infection, melanoma, and squamous cell carcinoma (SCC). BCCs can appear on any part of the body and often produce a bloody crust. AKs are scaly or hyperkeratotic lesions that can become malignant and are common in individuals over 60 years old. Herpes zoster infection causes a rash that is usually unilateral and follows a dermatomal distribution. Melanoma is a malignant tumour that arises from cutaneous melanocytes and can take on different types. SCC is the second most common type of skin cancer and arises from the keratinocytes of the epidermis. It predominantly affects sun-exposed sites and has a firm, indurated appearance with surrounding inflammation. BCCs are commonly found in sun-exposed areas and have a pearly appearance with rolled edges and surrounding telangiectasia. Management for skin cancer varies depending on the type and severity, but removal through curettage or excision is common for BCCs.

Henoch-Schönlein Purpura: A Common Childhood Vasculitis

Henoch-Schönlein purpura (HSP) is a common vasculitis of childhood that affects small vessels. It typically occurs in children, with 50% of cases in under-5s. The exact cause of the immune-mediated vasculitis is unknown, but it commonly follows a viral or streptococcal upper respiratory tract infection (URTI). Classic features include a non-blanching rash (palpable purpura, usually of the lower limbs), abdominal pain, arthralgia, and renal involvement/glomerulonephritis.

Possible complications of HSP include glomerulonephritis and renal failure, gastrointestinal bleed/intussusception, and pulmonary hemorrhage. Treatment is usually supportive, and the condition is self-limiting in most patients.

Other conditions, such as intertrigo, meningococcal disease, slapped cheek disease, and systemic lupus erythematosus (SLE), may present with similar symptoms but have distinct differences. For example, intertrigo affects skinfolds, meningococcal disease presents with red flags such as fever and headache, slapped cheek disease has a facial rash that precedes a rash on the limbs, and SLE typically has vague and insidious systemic symptoms before skin changes.

Investigations for HSP include bloods, blood pressure monitoring, and urinalysis. Treatment usually involves observation and monitoring, with non-steroidal anti-inflammatory drugs used for pain relief and sometimes corticosteroids given.

In summary, HSP is a common childhood vasculitis that presents with a non-blanching rash, abdominal pain, arthralgia, and renal involvement. It often follows a recent illness such as an upper respiratory tract infection and is usually self-limiting. Other conditions may present with similar symptoms but have distinct differences.

Common Causes of Ocular Symptoms: A Brief Overview

Giant Cell Arteritis: A large-vessel vasculitis that affects the temporal and ophthalmic arteries, causing headache, scalp tenderness, jaw pain, and visual disturbance. It is more common in females over the age of 70. In clinical practice, temporal artery biopsies performed for evaluation of patients with suspected GCA are positive in 25 to 35 percent of cases. So in this case this is the most likely diagnosis even in the absence of a positive biopsy.

Polyarteritis Nodosa (PAN): A necrotising vasculitis that can affect all age groups, but is more commonly associated with Hepatitis B. Symptoms include myalgia, arthralgia, fever, and weight loss. Ocular involvement is rare.

Diabetic Retinopathy: The most common cause of blindness in adults aged 30-65 in developed countries. Symptoms include microaneurysms, retinal haemorrhages, exudates, cotton wool spots, neovascularisation, and venous changes.

Sjögren Syndrome: An autoimmune disorder characterised by lymphocytic infiltration of salivary and lacrimal glands, resulting in dry eyes and dry mouth.

Central Retinal Vein Occlusion: Can occur in chronic simple glaucoma, arteriosclerosis, hypertension, and polycythaemia. Symptoms include a stormy sunset appearance of the fundus with red haemorrhagic areas and engorged veins.

Understanding Genital Warts

Genital warts, also known as condylomata accuminata, are a common reason for visits to genitourinary clinics. These warts are caused by various types of the human papillomavirus (HPV), with types 6 and 11 being the most common culprits. It is important to note that HPV, particularly types 16, 18, and 33, can increase the risk of cervical cancer.

The warts themselves are small, fleshy protrusions that are typically 2-5mm in size and may be slightly pigmented. They can cause discomfort, itching, and even bleeding. Treatment options for genital warts include topical podophyllum or cryotherapy, depending on the location and type of lesion. Topical agents are generally used for multiple, non-keratinised warts, while solitary, keratinised warts respond better to cryotherapy. Imiquimod, a topical cream, is often used as a second-line treatment. It is important to note that genital warts can be resistant to treatment, and recurrence is common. However, most anogenital HPV infections clear up on their own within 1-2 years without intervention.

Influenza Vaccination: Who Should Get It and What to Expect

Seasonal influenza remains a significant health concern in the UK, with the flu season typically starting in November. To prevent the spread of the virus, it is recommended that individuals receive the influenza vaccine between September and early November. There are three types of influenza virus, with types A and B causing the majority of clinical disease.

Prior to 2013, flu vaccination was only offered to the elderly and at-risk groups. However, a new NHS influenza vaccination programme for children was announced in 2013. The children’s vaccine is given intranasally, with the first dose administered at 2-3 years and subsequent doses given annually. It is a live vaccine and is more effective than the injectable vaccine.

Adults and at-risk groups are also recommended to receive the influenza vaccine annually. This includes individuals over 65 years old, those with chronic respiratory or heart disease, chronic kidney or liver disease, chronic neurological disease, diabetes mellitus, immunosuppression, asplenia or splenic dysfunction, pregnant women, and those with a body mass index of 40 kg/m² or higher. Health and social care staff, those living in long-stay residential care homes, and carers of the elderly or disabled person may also be eligible for the vaccine.

The influenza vaccine is an inactivated vaccine and cannot cause influenza. It is around 75% effective in adults, although this figure decreases in the elderly. It takes around 10-14 days after immunisation before antibody levels are at protective levels. The vaccine should be stored between +2 and +8ºC and shielded from light. Contraindications include hypersensitivity to egg protein. While a minority of patients may experience fever and malaise after receiving the vaccine, it is generally well-tolerated.

The most frequent cause of infective exacerbations of COPD is Haemophilus influenzae, according to research. This bacterium’s strains that cause COPD exacerbations are more virulent and induce greater airway inflammation than those that only colonize patients without causing symptoms. Patients with COPD have reduced mucociliary clearance, making them susceptible to H. influenzae, which can lead to airway inflammation and increased breathing effort. Coxsackievirus is linked to hand, foot, and mouth disease, which primarily affects children but can also affect immunocompromised adults. This option is incorrect because the patient does not have the typical symptoms of sore throat, fever, and maculopapular rash on hands, foot, and mucosa. Influenza A virus is associated with the bird flu pandemic and is not the most common cause of infective exacerbations of COPD. Staphylococcus aureus is not commonly associated with infective exacerbations of COPD. This bacterium is more commonly seen in mild cases of skin infections or can lead to infective endocarditis and is associated with biofilms causing infection.

Acute exacerbations of COPD are a common reason for hospital visits in developed countries. The most common causes of these exacerbations are bacterial infections, with Haemophilus influenzae being the most common culprit, followed by Streptococcus pneumoniae and Moraxella catarrhalis. Respiratory viruses also account for around 30% of exacerbations, with human rhinovirus being the most important pathogen. Symptoms of an exacerbation include an increase in dyspnea, cough, and wheezing, as well as hypoxia and acute confusion in some cases.

NICE guidelines recommend increasing the frequency of bronchodilator use and giving prednisolone for five days. Antibiotics should only be given if sputum is purulent or there are clinical signs of pneumonia. Admission to the hospital is recommended for patients with severe breathlessness, acute confusion or impaired consciousness, cyanosis, oxygen saturation less than 90%, social reasons, or significant comorbidity.

For severe exacerbations requiring secondary care, oxygen therapy should be used with an initial saturation target of 88-92%. Nebulized bronchodilators such as salbutamol and ipratropium should also be administered, along with steroid therapy. IV hydrocortisone may be considered instead of oral prednisolone, and IV theophylline may be used for patients not responding to nebulized bronchodilators. Non-invasive ventilation may be used for patients with type 2 respiratory failure, with bilevel positive airway pressure being the typical method used.